Labriola C, Cazzulo J J, Parodi A J
Instituto de Investigaciones Bioquímicas, Fundación Campomar, Buenos Aires, Argentina.
J Cell Biol. 1995 Aug;130(4):771-9. doi: 10.1083/jcb.130.4.771.
It has been proposed that the UDP-Glc:glycoprotein glucosyltransferase, an endoplasmic reticulum enzyme that only glucosylates improperly folded glycoproteins forming protein-linked Glc1Man7-9-GlcNAc2 from the corresponding unglucosylated species, participates together with lectin-like chaperones that recognize monoglucosylated oligosaccharides in the control mechanism by which cells only allow passage of properly folded glycoproteins to the Golgi apparatus. Trypanosoma cruzi cells were used to test this model as in trypanosomatids addition of glucosidase inhibitors leads to the accumulation of only monoglucosylated oligosaccharides, their formation being catalyzed by the UDP-Glc:glycoprotein glucosyltransferase. In all other eukaryotic cells the inhibitors produce underglycosylation of proteins and/or accumulation of oliogosaccharides containing two or three glucose units. Cruzipain, a lysosomal proteinase having three potential N-glycosylation sites, two at the catalytic domain and one at the COOH-terminal domain, was isolated in a glucosylated form from cells grown in the presence of the glucosidase II inhibitor 1-deoxynojirimycin. The oligosaccharides present at the single glycosylation site of the COOH-terminal domain were glucosylated in some cruzipain molecules but not in others, this result being consistent with an asynchronous folding of glycoproteins in the endoplasmic reticulum. In spite of not affecting cell growth rate or the cellular general metabolism in short and long term incubations, 1-deoxynojirimycin caused a marked delay in the arrival of cruzipain to lysosomes. These results are compatible with the model proposed by which monoglucosylated glycoproteins may be transiently retained in the endoplasmic reticulum by lectin-like anchors recognizing monoglucosylated oligosaccharides.
有人提出,UDP-葡萄糖:糖蛋白葡萄糖基转移酶是一种内质网酶,仅对折叠不当的糖蛋白进行糖基化,从相应的未糖基化物种形成蛋白质连接的Glc1Man7-9-GlcNAc2,它与识别单糖基化寡糖的凝集素样伴侣一起参与细胞仅允许正确折叠的糖蛋白进入高尔基体的控制机制。克氏锥虫细胞被用于测试该模型,因为在锥虫中添加葡萄糖苷酶抑制剂只会导致单糖基化寡糖的积累,其形成由UDP-葡萄糖:糖蛋白葡萄糖基转移酶催化。在所有其他真核细胞中,抑制剂会导致蛋白质糖基化不足和/或含有两个或三个葡萄糖单元的寡糖积累。克鲁兹蛋白酶是一种溶酶体蛋白酶,有三个潜在的N-糖基化位点,两个在催化结构域,一个在COOH末端结构域,从在葡萄糖苷酶II抑制剂1-脱氧野尻霉素存在下生长的细胞中分离出糖基化形式的该酶。COOH末端结构域单个糖基化位点上的寡糖在一些克鲁兹蛋白酶分子中被糖基化,但在其他分子中未被糖基化,这一结果与内质网中糖蛋白的异步折叠一致。尽管在短期和长期培养中不影响细胞生长速率或细胞的一般代谢,但1-脱氧野尻霉素导致克鲁兹蛋白酶到达溶酶体的过程明显延迟。这些结果与所提出的模型相符,即单糖基化糖蛋白可能通过识别单糖基化寡糖的凝集素样锚定物在内质网中短暂保留。